Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  



Merck sued over Fosamax

Lawsuits are getting under way following reports linking the osteoporosis drug, Merck's second biggest seller, to cases of necrosis (tissue death) of the jaw. Kevin Pho (first, second post) has been covering the story, as has PharmaGossip.



Isaac Gorodetski
Project Manager,
Center for Legal Policy at the
Manhattan Institute

Katherine Lazarski
Press Officer,
Manhattan Institute


Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.